Archit Organosys Intrinsic Value
ARCHITORG Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹41.76 | ₹33.41 - ₹50.11 | -0.5% | EPS: ₹3.48, Sector P/E: 12x |
| Book Value Method | asset | ₹30.48 | ₹27.43 - ₹33.53 | -27.3% | Book Value/Share: ₹30.48, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹53.33 | ₹48.00 - ₹58.66 | +27.1% | Revenue/Share: ₹66.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹43.57 | ₹39.21 - ₹47.93 | +3.9% | EBITDA: ₹16.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹44.21 | ₹35.37 - ₹53.05 | +5.4% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹22.27 | ₹20.04 - ₹24.50 | -46.9% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹28.68 | ₹25.81 - ₹31.55 | -31.6% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹45.71 | ₹41.14 - ₹50.28 | +9.0% | ROE: 12.5%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹48.85 | ₹43.97 - ₹53.74 | +16.4% | EPS: ₹3.48, BVPS: ₹30.48 |
Want to compare with current market value? Check ARCHITORG share price latest .
Valuation Comparison Chart
ARCHITORG Intrinsic Value Analysis
What is the intrinsic value of ARCHITORG?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Archit Organosys (ARCHITORG) is ₹43.57 (median value). With the current market price of ₹41.95, this represents a +3.9% variance from our estimated fair value.
The valuation range spans from ₹22.27 to ₹53.33, indicating ₹22.27 - ₹53.33.
Is ARCHITORG undervalued or overvalued?
Based on our multi-method analysis, Archit Organosys (ARCHITORG) appears to be trading near calculated value by approximately 3.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.20 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.69 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 12.5% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | -1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.30x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Archit Organosys
Additional stock information and data for ARCHITORG
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹10 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹17 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |